{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7xFE3SwyOSa","type":"doc","o":"1","documentId":"ucms_7xFE3SwyOSa"},"body":{"newStatus":"1","documentId":"ucms_7xFE3SwyOSa","staticId":"ucms_7xFE3SwyOSa","title":"现代制药:克拉霉素片获得仿制药一致性评价","shareTitle":"现代制药:克拉霉素片获得仿制药一致性评价","thumbnail_doc":"","thumbnail":"","source":"证券时报","author":"","editorcode":"weMedia","editTime":"2020-06-12 15:56:22","updateTime":"2020\/06\/12 15:56:22","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7xFE3SwyOSa","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7xFE3SwyOSa","commentsUrl":"ucms_7xFE3SwyOSa","commentCount":0,"text":"
证券时报e公司讯,现代制药(600420)6月12日晚间公告,公司近日收到批件,批准克拉霉素片通过仿制药一致性评价。克拉霉素片适用于克拉霉素敏感菌所引起的感染:鼻炎感染、下呼吸道感染等,也用于军团菌感染或与其他药物联合用于鸟分支杆菌感染、幽门螺旋杆菌感染的治疗。数据显示,克拉霉素2019年在全国城市样本公立医院的销售额为8.19亿元。公司克拉霉素片通过一致性评价将有利于提升该产品未来的市场销售和市场竞争。<\/p>","img":[],"summary":"证券时报e公司讯,现代制药(600420)6月12日晚间公告,公司近日收到批件,批准克拉霉素片通过仿制药一致性评价。克拉霉素片适用于克拉霉素敏感菌所引起的感染:","sharesummary":"证券时报e公司讯,现代制药(600420)6月12日晚间公告,公司近日收到批件,批准克拉霉素片通过仿制药一致性评价。克拉霉素片适用于克拉霉素敏感菌所引起的感染:","commentType":"0","wemediaEAccountId":"706","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002PY6XUkPtoxfF9hdsPSCC6hjWLfw-_3lO86tljdyD4Om0__","praise":"0","like_num":"0"}}